GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups
Information source: Bayer
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Diabetes Mellitus
Intervention: Acarbose, Glucobay (BAYG5421) (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Bayer Official(s) and/or principal investigator(s):
Bayer Study Director, Study Director, Affiliation: Bayer
Overall contact:
Bayer Clinical Trials Contact, Email: clinical-trials-contact@bayerhealthcare.com
Summary
Evaluation of safety and effectiveness of Glucobay® under daily-life treatment conditions in
a large sample of patients.
Clinical Details
Official title: Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups
Study design: Cohort, Prospective
Primary outcome: Data collection on patients weight and waist circumference, fasting blood glucose, postprandial blood glucose (2h), HbA1C; exploratory analysis according to patient groups (concomitant cardiovascular disease groups, BMI)
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Patients with untreated or pretreated diabetes mellitus or patients for which
acarbose is indicated and without acarbose treatment within the last three months
before study inclusion. The decision for treatment type and duration is taken by the
investigator and is made before inclusion into the study.
Exclusion Criteria:
- Exclusion criteria must be read in conjunction with the local product information.
Locations and Contacts
Bayer Clinical Trials Contact, Email: clinical-trials-contact@bayerhealthcare.com
Many Locations, Bosnia and Herzegovina; Not yet recruiting
Many Locations, Cambodia; Not yet recruiting
Many Locations, China; Recruiting
Many Locations, Hong Kong; Recruiting
Many Locations, India; Not yet recruiting
Many Locations, Indonesia; Recruiting
Many Locations, Korea, Republic of; Not yet recruiting
Many Locations, Malaysia; Not yet recruiting
Many Locations, Moldova, Republic of; Not yet recruiting
Many Locations, Pakistan; Recruiting
Many Locations, Philippines; Not yet recruiting
Many Locations, Russian Federation; Not yet recruiting
Many Locations, Singapore; Not yet recruiting
Many Locations, Thailand; Recruiting
Additional Information
Click here and search for drug information provided by the FDA Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product Click here to find results for studies related to marketed products
Starting date: May 2009
Ending date: June 2010
Last updated: October 12, 2009
|
